BACKGROUND WHO expert groups recommended mortality trials in hospitalized COVID-19 of four re-purposed antiviral drugs. METHODS Study drugs were Remdesivir, Hydroxychloroquine, Lopinavir (fixed-dose combination with Ritonavir) and Interferon-β1a...
Tata group has received approval from the Drug Controller General of India (DCGI) for the commercial launch of the country's first CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) coronavirus test 'Feluda', the Council of...
Dale YuzukiNow this is surprising: Tata group to launch India's first CRISPR coronavirus test 'Feluda' | India TV News
I’m running a book or magazine cover contest on 99designs. Designers have submitted 223 designs so far. Please vote on your favorite as I’d love to receive your feedback.
Dale YuzukiInterested in books? Would you like to help choose a cover? I'm writing a book to launch 23 Nov 2020 called COVID-19: From Chaos to Cure, with the subtitle Behind the biology in our war against the novel coronavirus. This is for the non-expert!
Dale YuzukiA new upcoming book, COVID-19: From Chaos to Cure, is being prepared for launch this Nov 23. I wrote a short post pointing out a few things I've learned about cover design through this process. daleyuzuki.com/2020/09/we-all… Consider signing up for periodic blog updates!
What are the announcements you may ask? You’ll need to read about it below. The experience of working to build something from nothing is invaluable. And I am happy to announce that I am now officially…
Dale YuzukiPost Edited: A Pair of Announcements – The Adventure Continues
Dale YuzukiNew post: A Pair of Announcements – The Adventure Continues